Konan Medical’s objective FIELD(R) Perimeter Obtains CE Mark Under MDR

3 months ago

objectiveFIELD is the first and only truly objective perimeter FDA 510(k) cleared to assess visual field abnormalitiesIrvine, California--(Newsfile Corp. -…

Infinx Invests in Voxology AI to Bring Conversational AI Agents to Patient Scheduling

3 months ago

Strategic Partnership Adds AI Scheduling Agents to Infinx's Healthcare Revenue Cloud Platform, Helping Providers Reduce Hold Times, Improve Patient Access…

Infinx Invests in Voxology AI to Bring Conversational AI Agents to Patient Scheduling

3 months ago

Strategic Partnership Adds AI Scheduling Agents to Infinx's Healthcare Revenue Cloud Platform, Helping Providers Reduce Hold Times, Improve Patient Access…

Omaha Staffing Executive Honored on SIA Global Power 150 List

3 months ago

The Global Power 150 list is not a ranking but a contemporary look at the most influential women in staffing.…

The Korean Trio Shines Out at ECRM for Its Detoxifying Nutraceuticals

3 months ago

Anathapindika Health’s Signature Nutraceuticals Draw Attention, Impress Buyers at the September Nutraceutical Conference — Just in Time to Gain Momentum…

WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance

3 months ago

Hangzhou, China, Oct. 10, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”),…

Aytu BioPharma to Present at Upcoming October 2025 Conferences

3 months ago

DENVER, CO / ACCESS Newswire / October 10, 2025 /Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company…

YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities 

3 months ago

Taipei, Taiwan, Oct. 10, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology…

Ensysce Biosciences Releases Symposium Highlights from PAINWeek 2025

3 months ago

~ Pain Management, RE-Invented: Ushering in a New Era for Analgesia ~ SAN DIEGO, CA / ACCESS Newswire / October…

Annovis Announces $6 Million Registered Direct Offering of Common Stock

3 months ago

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical…